| 发明名称 |
V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level |
| 摘要 |
<p>The present invention relates to a vasopressin receptor 1B (V1B) antagonist for use in the treatment of depressive symptoms and/or anxiety symptoms in patients showing an elevated arginine vasopressin (AVP) level and/or an elevated copeptin level. The present invention further relates to a method for predicting the treatment response to a V1B antagonist in patients with depressive symptoms and/or anxiety symptoms.</p> |
| 申请公布号 |
GB201210686(D0) |
申请公布日期 |
2012.08.01 |
| 申请号 |
GB20120010686 |
申请日期 |
2012.06.15 |
| 申请人 |
HOLSBOERMASCHMEYER NEUROCHEMIE GMBH |
发明人 |
|
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
